When Patent Rules Diverge, Context Becomes the Competitive Advantage

Global patent activity looks relatively stable from a distance. WIPO reported 275,900 international PCT applications in 2025, an increase of just 0.7%.

Underneath that topline, filing behavior is changing. Biotechnology PCT filings declined 3.9% in 2025 and medical technology filings fell 3.0%. PCT national phase entries, the step that turns an international application into protection pursued in individual countries, fell 3.7% in 2024, the second consecutive annual decline.

The data does not tell us why each applicant made a particular decision. It does suggest that organizations are becoming more selective about where they pursue protection. At the same time, the rules shaping those decisions are becoming more jurisdiction-specific. In this article, Hugh McCallion, Director, Legal Solutions & Market Strategy at Park IP, explores how connected technology and specialized IP expertise can help legal teams navigate these differences and make more informed portfolio decisions.

Expert Hugh McCallion

Sr. Director, Legal Solutions & Market Strategy | Park IP

Show Profile

One Portfolio, Several Changing Rulebooks

Recent developments show how quickly the considerations behind a global portfolio can change.

European Union: The EU pharma reform package broadens and harmonizes the Bolar exemption, allowing more launch preparation for generics and biosimilars while an originator patent remains in force. The change does not shorten the patent term, but it can narrow the practical gap between patent expiry and competitor launch. Although the reform does not shorten patent terms, it could reduce the time between patent expiry and competitor market entry. The Council formally adopted its position on September 28, 2026, with final European Parliament approval expected in November. The expanded exemption is expected to apply in late 2028 or early 2029, following national implementation.

China: In a 2025 decision involving semaglutide,  the Supreme People's Court indicated that experimental data submitted after filing may support inventive step, provided the claimed effect was described in, or can be derived from, the original application. The ruling upheld the lower court's decision to overturn the patent's invalidation and clarified the circumstances under which supplementary experimental evidence may be accepted (Case No. (2023) SPC IP Admin. Final 1282).

South Korea: Amendments to the Patent Act effective July 22, 2025, limit patent term extensions to one patent per approved drug, for approvals granted on or after that date. The changes also cap the extended patent term at 14 years from the drug's approval date, requiring patent owners to make more deliberate decisions about which patent to extend.

These developments do not point in one direction. Some expand options, some narrow them, and others clarify existing practice. Together, they increase the jurisdiction-specific information legal teams must weigh in filing, prosecution, and commercialization decisions.

Information Alone Is Not Enough

AI is already helping IP teams search documents, summarize information, classify records, and automate routine workflows. Those uses remain important. The greater opportunity is to connect that efficiency to context.

A system can summarize a regulatory update in seconds. The harder question is whether the update should change a drafting approach, filing priority, patent term decision, launch assumption, or budget allocation. Answering it takes reliable source material, portfolio data, jurisdictional knowledge, and an understanding of the organization's commercial priorities.

Connected platforms can bring these elements together. Instead of treating search, filing activity, deadlines, costs, and jurisdictional requirements as separate datasets, they surface relevant information inside the workflow where a decision is made.

Legal Studio by Park IP applies this principle to global IP execution. It brings together instant PCT cost estimates, jurisdiction-aware workflows, translation and filing coordination, status tracking, and alerts. Consider a team weighing national phase entry across several countries: seeing projected costs, local requirements, and deadlines in one place lets them test options before committing, rather than reconciling spreadsheets and emails afterward. Its AI-enabled quality process flags higher-risk content for expert review, while experienced IP professionals remain responsible for quality and judgment.

The value lies in making the right information visible at the right point in the process, not in asking technology to make the legal decision.

Automation and Judgment Work Together

AI does not need to replace professional judgment to create value. It can reduce the administrative effort of gathering information, highlight relationships across a portfolio, and help teams see where expert attention is most needed. Legal professionals still decide what the evidence means for their organization: its risk tolerance, its commercial priorities, and the legal significance of a rule that may be interpreted differently across jurisdictions.

As filing strategies become more selective and patent rules continue to diverge, that combination of technology and expertise becomes more important. The most useful measure of legal AI may be simple: does it help IP professionals see the relevant evidence sooner, understand how the pieces connect, and make a more informed and defensible decision?

For global patent teams, that is where practical advantage begins.

See it in action

Want to see how connected PCT cost visibility and workflow control work in practice? Book a Legal Studio demo and walk through a live example with the Park IP team.

About Park IP

Park IP, a Welo Global brand, helps law firms and corporate legal teams protect intellectual assets across jurisdictions. Park IP combines experienced IP professionals with AI-enabled workflows supporting global patent translation, foreign filing, litigation, and compliance. Its Legal Studio workspace provides greater visibility and control across multilingual IP activity while keeping expert accountability at the center of the process

Do you like what you read? Share this post or leave us a comment!

Comments

No Comments

Write comment

* These fields are required